Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safeguarding America's Pharmaceuticals Act of 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2013 · second_quarter · Q2
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Source: Senate LDA
End Anonymous Patents Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Intellectual Property International Enforcement Compulsory LicensingPatent Reform Implementation of H.R. 1249: The America Invents Act of 2011 House Judiciary Committee Discussion Draft H.R. 2024: End Anonymous Patents Act H.R. 845: The SHIELD Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 866: Patent Quality Improvement Act of 2013 DNA Patenting and Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Health Regulatory Agency Review of Patents Brazil Colombia Asia Pacific Economic Cooperation Forum Intellectual Property Issues Drug Patent Settlements
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
To prohibit the use of funds for the rule entitled "Provisional Unlawful Presence Waivers of Inadmissibility for Certain Immediate Relatives" published by the Department of Homeland Security on January 3, 2013 (78 Fed. Reg. 535).
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Intellectual Property International Enforcement Compulsory LicensingPatent Reform Implementation of H.R. 1249: The America Invents Act of 2011 House Judiciary Committee Discussion Draft H.R. 2024: End Anonymous Patents Act H.R. 845: The SHIELD Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 866: Patent Quality Improvement Act of 2013 DNA Patenting and Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Health Regulatory Agency Review of Patents Brazil Colombia Asia Pacific Economic Cooperation Forum Intellectual Property Issues Drug Patent Settlements
Patent Abuse Reduction Act of 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Intellectual Property International Enforcement Compulsory LicensingPatent Reform Implementation of H.R. 1249: The America Invents Act of 2011 House Judiciary Committee Discussion Draft H.R. 2024: End Anonymous Patents Act H.R. 845: The SHIELD Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 866: Patent Quality Improvement Act of 2013 DNA Patenting and Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Health Regulatory Agency Review of Patents Brazil Colombia Asia Pacific Economic Cooperation Forum Intellectual Property Issues Drug Patent Settlements
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Upper Mississippi Conservation and River Protection Act of 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Patent Quality Improvement Act of 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Intellectual Property International Enforcement Compulsory LicensingPatent Reform Implementation of H.R. 1249: The America Invents Act of 2011 House Judiciary Committee Discussion Draft H.R. 2024: End Anonymous Patents Act H.R. 845: The SHIELD Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 866: Patent Quality Improvement Act of 2013 DNA Patenting and Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Health Regulatory Agency Review of Patents Brazil Colombia Asia Pacific Economic Cooperation Forum Intellectual Property Issues Drug Patent Settlements
Drug Supply Chain Security Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Pharmaceutical Quality, Security, and Accountability Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform LitigationTransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl World Trade Organization Special 301 Submissions Generic Drug Patent Settlements S. Con. Res. 8: Senate Budget Resolution Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Intellectual Property International Enforcement Compulsory Licensing International Patent Law Harmonization Patent Exhaustion
Drug Safety Enhancement Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Drug Safety Enhancement Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Generating Antibiotic Incentives Now Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Generating Antibiotic Incentives Now Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Preserving Access to Life-Saving Medications Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health National Center for Advancing Translational Sciences (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Federal Response to the Rising Rates of Autism Tax for Seasonal Influenza Funding H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Drug Safety and Review E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft) Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012 Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement S 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 HHS Countermeasures Review TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act Medicaid Rebates
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Food and Drug Administration Mission Reform Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Food and Drug Administration Mission Reform Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
FAST Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
FAST Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health National Center for Advancing Translational Sciences (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Federal Response to the Rising Rates of Autism Tax for Seasonal Influenza Funding H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Drug Safety and Review E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft) Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012 Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement S 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 HHS Countermeasures Review TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act Medicaid Rebates
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
To correct and improve certain provisions of the Leahy-Smith America Invents Act and title 35, United States Code.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 6621: To correct and improve certain provisions of the Leahy-Smith America Invents Act Intellectual Property International Enforcement Compulsory Licensing Patient Revocations Indonesian Issues Indian Issues World Trade Organization Special 301 Submissions International Trade Commission Reform Rep. Devin Nunes Discussion Draft TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Export Registrations for Products with Expired Patents
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Funding for National Institutes of Health National Center for Advancing Translational Sciences (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Federal Response to the Rising Rates of Autism Tax for Seasonal Influenza Funding H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Drug Safety and Review E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft) Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012 Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement S 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 HHS Countermeasures Review TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act Medicaid Rebates
Preserving Access to Life-Saving Medications Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Vaccine Access/Financing S. 1094: Combating Autism Reauthorization Act Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review Regulatory Reforms for Innovative Products Prescription Drug User Fee Act (PDUFA) Reauthorization Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Policies and Regulation
Preserving Access to Life-Saving Medications Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590:(Senate) Patient Protection and Affordable Care Act Reimbursement Issues Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation
Preserving Access to Life-Saving Medications Act of 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Federal Supply Schedule Access During Emergencies Expanded Access to Experimental Products Medicaid Rebates Dual Eligibles S 365: Budget Control Act of 2011 Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Part D Prescription Drug Program International Biosecurity Policies Biologics and Toxins Weapons Convention
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Vaccine Access/Financing S. 1094: Combating Autism Reauthorization Act Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review Regulatory Reforms for Innovative Products Prescription Drug User Fee Act (PDUFA) Reauthorization Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Policies and Regulation
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590:(Senate) Patient Protection and Affordable Care Act Reimbursement Issues Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Federal Supply Schedule Access During Emergencies Expanded Access to Experimental Products Medicaid Rebates Dual Eligibles S 365: Budget Control Act of 2011 Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Part D Prescription Drug Program International Biosecurity Policies Biologics and Toxins Weapons Convention
Combating Autism Reauthorization Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Vaccine Access/Financing S. 1094: Combating Autism Reauthorization Act Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review Regulatory Reforms for Innovative Products Prescription Drug User Fee Act (PDUFA) Reauthorization Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Policies and Regulation
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 Patent Reform Cont... Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act S.4322: Preserve Access to Affordable Generics Act PTO Administrative Reforms World Trade Organization Special 301 Submissions Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Possible Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act (Discussion Draft) Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
America's Healthy Future Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Low-level Presence Foreign Government Policies North America Biotechnology Initiative World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation H.R. 3590: (Senate) Patient Protection and Affordable Care Act S.1796: America's Health Future Act of 2009 H.R. 4872: Health Care and Education Reconciliation Act of 2010 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Department of Homeland Security Appropriations Act for FY 2011 Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning Alliance for Healthcare Competitiveness Funding for International Trade Activities at the USDA (Office of the Secretary & Food Safety Inspection Service, Foreign Agricultural Service) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations Discussions with EU on Animal Cloning China Biotechnology Regulations APEC Agricultural Biotechnology Discussions Low-Level Presence Foreign Government Policies Korea Biotechnology Regulations EU Biotechnology Bilateral Discussions Turkish Biotechnology Regulations Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Drug Importation S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 S. 3607: Department of Homeland Security Appropriations Act for FY 2011 S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Export Registrations for Products with Expired Patents Alliance for Healthcare Competitiveness U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Transpacific Partnership Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning U.S. Policy on International Science-Based Regulations Drug Importation S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 S.3607: Department of Homeland Security Appropriations Act for FY 2011 S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement EU Biotechnology Bilateral Discussions China Biotechnology Regulations Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity
Department of Homeland Security Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning U.S. Policy on International Science-Based Regulations Drug Importation S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 S.3607: Department of Homeland Security Appropriations Act for FY 2011 S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement EU Biotechnology Bilateral Discussions China Biotechnology Regulations Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity
Department of Homeland Security Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations Discussions with EU on Animal Cloning China Biotechnology Regulations APEC Agricultural Biotechnology Discussions Low-Level Presence Foreign Government Policies Korea Biotechnology Regulations EU Biotechnology Bilateral Discussions Turkish Biotechnology Regulations Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Drug Importation S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 S. 3607: Department of Homeland Security Appropriations Act for FY 2011 S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Export Registrations for Products with Expired Patents Alliance for Healthcare Competitiveness U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Transpacific Partnership Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity
Financial Services and General Government Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act for 2011 H.R. 3082: 4th Continuing Appropriations Act for FY 2011 S. 4322: Preserve Access to Affordable Generics Act Patent Reform S. 515: The Patent Reform Act of 2009 Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity DNA Patenting and Licensing Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Patent Presumption of Validity Amicus Matters
Financial Services and General Government Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Three Track Examination Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act of 2011 H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity DNA Patenting and Licensing Amicus Matters Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement Compulsory Licensing
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations Discussions with EU on Animal Cloning China Biotechnology Regulations APEC Agricultural Biotechnology Discussions Low-Level Presence Foreign Government Policies Korea Biotechnology Regulations EU Biotechnology Bilateral Discussions Turkish Biotechnology Regulations Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Drug Importation S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 S. 3607: Department of Homeland Security Appropriations Act for FY 2011 S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Export Registrations for Products with Expired Patents Alliance for Healthcare Competitiveness U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Transpacific Partnership Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning U.S. Policy on International Science-Based Regulations Drug Importation S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 S.3607: Department of Homeland Security Appropriations Act for FY 2011 S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement EU Biotechnology Bilateral Discussions China Biotechnology Regulations Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 Patent Reform Cont... Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act S.4322: Preserve Access to Affordable Generics Act PTO Administrative Reforms World Trade Organization Special 301 Submissions Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act for 2011 H.R. 3082: 4th Continuing Appropriations Act for FY 2011 S. 4322: Preserve Access to Affordable Generics Act Patent Reform S. 515: The Patent Reform Act of 2009 Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity DNA Patenting and Licensing Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Patent Presumption of Validity Amicus Matters
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Possible Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act (Discussion Draft) Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Possible Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act (Discussion Draft) Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 Patent Reform Cont... Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act S.4322: Preserve Access to Affordable Generics Act PTO Administrative Reforms World Trade Organization Special 301 Submissions Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement
Montgomery GI Bill Degree Extension Act of 2007
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act for 2011 H.R. 3082: 4th Continuing Appropriations Act for FY 2011 S. 4322: Preserve Access to Affordable Generics Act Patent Reform S. 515: The Patent Reform Act of 2009 Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity DNA Patenting and Licensing Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Patent Presumption of Validity Amicus Matters
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Low-level Presence Foreign Government Policies North America Biotechnology Initiative World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation H.R. 3590: (Senate) Patient Protection and Affordable Care Act S.1796: America's Health Future Act of 2009 H.R. 4872: Health Care and Education Reconciliation Act of 2010 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Department of Homeland Security Appropriations Act for FY 2011 Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning Alliance for Healthcare Competitiveness Funding for International Trade Activities at the USDA (Office of the Secretary & Food Safety Inspection Service, Foreign Agricultural Service) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 Patent Reform Cont... Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act S.4322: Preserve Access to Affordable Generics Act PTO Administrative Reforms World Trade Organization Special 301 Submissions Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Three Track Examination Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act of 2011 H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity DNA Patenting and Licensing Amicus Matters Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement Compulsory Licensing
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization and Convention on Biological Diversity Patent Disclosure Requirements Special 301 Submissions/Meetings Bayh-Dole Act/Gene Patenting Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Bayh-Dole Act/Tech Transfer Gene Patenting HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Proposed Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009
21st Century Energy Technology Deployment Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
21st Century Energy Technology Deployment Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
21st Century Energy Technology Deployment Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S. 949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009
American Recovery and Reinvestment Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
American Recovery and Reinvestment Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patient-Centered Outcomes Research Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009
Algae-based Renewable Fuel Promotion Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Algae-based Renewable Fuel Promotion Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Algae-based Renewable Fuel Promotion Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Algae-based Renewable Fuel Promotion Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production Livestock Cloning/Product Labeling Cont... USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product From GE Animals Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016) Efficient Review of Biotech Products U.S. Policy on Sustainable Agriculture Standard American National Standards Institute Sustainable Agriculture Standards (ANSI) International Standards Organization Standard (ISO) Funding for the USDA H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Biomass Crop Assistance Program (BCAP) BCAP Rulemaking and Environmental Impact Statement 2007 Farm Bill Implementation H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 U.S. Government Agriculture Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Agriculture Federal Research Initiative for FY 2009 Global Food Security Initiative U.S. Government Strategy for Global Food Security Codex Alimentarius Commission Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance UN Climate Change Convention US Government Position on Ag-biotech and Intellectual Property Rights
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009
Energy and Water Development and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Energy and Water Development and Related Agencies Appropriations Act, 2010
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Clean Energy Jobs and American Power Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 S. 1733: Clean Energy Jobs and American Power Act of 2009 U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change Benefits of Biofuels and Bio-based Products Cont... Bio-based Products Tax Credit IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change/Indirect Land Use H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for 2010 H.R. 2454: American Clean Energy and Security Act of 2009 S.1733: Clean Energy Jobs and American Power Act of 2009
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Proposed Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization and Convention on Biological Diversity Patent Disclosure Requirements Special 301 Submissions/Meetings Bayh-Dole Act/Gene Patenting Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Bayh-Dole Act/Tech Transfer Gene Patenting HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
Patent Reform Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Colombia Biotechnology Bilateral Discussions Negotiations of Trans Pacific Partnership APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
Intellectual Property International Enforcement Compulsory LicensingPatent Reform Implementation of H.R. 1249: The America Invents Act of 2011 House Judiciary Committee Discussion Draft H.R. 2024: End Anonymous Patents Act H.R. 845: The SHIELD Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 866: Patent Quality Improvement Act of 2013 DNA Patenting and Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Health Regulatory Agency Review of Patents Brazil Colombia Asia Pacific Economic Cooperation Forum Intellectual Property Issues Drug Patent Settlements
Livestock Cloning/Product Labeling Discussions with EU on Animal CloningIntellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations EU Biotechnology Bilateral Discussions, Low-Level Presence Foreign Government Policies TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Sanitary and Phytosanitary Issues Transatlantic Trade and Investment Partnership Ag-Biotech Issues Intellectual Property Issues Regulatory Harmonization Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics Regulations Biosimilars Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2013 · first_quarter · Q1
Patent Reform LitigationTransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl World Trade Organization Special 301 Submissions Generic Drug Patent Settlements S. Con. Res. 8: Senate Budget Resolution Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Intellectual Property International Enforcement Compulsory Licensing International Patent Law Harmonization Patent Exhaustion
Livestock Cloning/Product Labeling Discussions with EU on Animal CloningWorld Trade Organization Special 301 Submissions Export Registrations for Products with Expired Patents Intellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations China Biotechnology Regulations Low-Level Presence Foreign Government Policies International Biotechnology Agreement Asynchrony of International Approvals EU Biotechnology Bilateral Discussions TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl Regulatory Transparency Sanitary and Phytosanitary Issues U.S./European Union High-Level Dialogue on Regulatory Issues
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2012 · fourth_quarter · Q4
Funding for National Institutes of Health National Center for Advancing Translational Sciences (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Federal Response to the Rising Rates of Autism Tax for Seasonal Influenza Funding H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Drug Safety and Review E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft) Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012 Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement S 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 HHS Countermeasures Review TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act Medicaid Rebates
Patent Reform H.R. 6621: To correct and improve certain provisions of the Leahy-Smith America Invents Act Intellectual Property International Enforcement Compulsory Licensing Patient Revocations Indonesian Issues Indian Issues World Trade Organization Special 301 Submissions International Trade Commission Reform Rep. Devin Nunes Discussion Draft TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Export Registrations for Products with Expired Patents
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents World Trade Organization Special 301 Submissions International Trade Commission Reform Rep. Devin Nunes Discussion Draft Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Asynchrony of International Approvals TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Intellectual Property International Enforcement Compulsory Licensing Patient Revocations Indonesian Issues Indian Issues
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2012 · third_quarter · 3A
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Sanitary and Phytosanitary Issues Regulatory Transparency International Trade Commission Reform Rep. David Nunes Discussion Draft Intellectual Property International Enforcement Biosimilars Colombia Biologics Regulations Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations International Biotechnology Agreement Asynchrony of International Approvals
Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Australia Compulsory Licensing Parliamentary Inquiry Confirmatory Genetic Diagnostic Testing Intellectual Property International Enforcement Patent Exhaustion Ag-biotech Products International Trade Commission Reform Rep. Devin Nunes Discussion Draft TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Patent Reform Implementation of the America Invents Act of 2011
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2012 · third_quarter · Q3
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Sanitary and Phytosanitary Issues Regulatory Transparency International Trade Commission Reform Rep. David Nunes Discussion Draft Intellectual Property International Enforcement Biosimilars Colombia Biologics Regulations Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations International Biotechnology Agreement Asynchrony of International Approvals
Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Australia Compulsory Licensing Parliamentary Inquiry Confirmatory Genetic Diagnostic Testing Intellectual Property International Enforcement Patent Exhaustion Ag-biotech Products International Trade Commission Reform Rep. Devin Nunes Discussion Draft TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Patent Reform Implementation of the America Invents Act of 2011
Pharmaceutical Industry Annual Fee Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Treasury and IRS Regulations Implementing the Law Biosimilars Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Colombia Biologics Regulations Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translations Science (NCATS) S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Taxable Vaccines Act (Discussion Draft) 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act Average Manufacturer Price Calculations Therapeutic Discovery Project Tax Credit S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Access to External Experts Conflicts of Interest Drug Shortages E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discussion Draft) Expedited Approval Pathways FDA Mission Regulatory Reforms for Innovative Products Supply Chain Integrity Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development, and Procurement HHS Countermeasures Review S.1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees Implementation of P.L. No: 112-25: Budget Control Act
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2012 · second_quarter · Q2
Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 Technical Corrections of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions India Issues Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Confirmatory Genetic Diagnostic Testing Subject Matter Eligibility Intellectual Property International Enforcement International Trade Commission Reform Rep. Devin Nunes Discussion Draft TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Patent Exhaustion Ag-biotech Products Process Patents Subject Matter Eligibility PTO Guidance
Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement Issues Comparative Effectiveness Research Initiatives Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translation Science (NCATS) S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Tax for Seasonal Influenza Funding Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts FDA Globalization Act (Discussion Draft) Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft H.R.4132: Faster Access to Specialized Treatments (FAST) Act S. 3187:The Food and Drug Administration Safety and Innovation Act S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement (Non-Funding Issues) S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Therapeutic Discovery Project Tax Credit Extension S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2012 · first_quarter · Q1
Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Intellectual Property International Enforcement Compulsory Licensing International IP Patent Law Harmonization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning World Trade Organization Special 301 Submissions Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies, China Biotechnology Regulations Discussions with EU on Animal Cloning EU Biotechnology Bilateral Discussions European Union Low Level Presence Policy International Biotechnology Agreement Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Sanitary and Phytosanitary Issues
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2011 · fourth_quarter · Q4
Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions China Issues Finland Issues Russia Issues Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement International IP Patent Law Harmonization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Federal Supply Schedule Access During Emergencies Expanded Access to Experimental Products Medicaid Rebates Dual Eligibles S 365: Budget Control Act of 2011 Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Part D Prescription Drug Program International Biosecurity Policies Biologics and Toxins Weapons Convention
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2011 · third_quarter · Q3
Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590:(Senate) Patient Protection and Affordable Care Act Reimbursement Issues Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2011 · second_quarter · Q2
Patent Reform H.R. 1249: The Leahy-Smith America Invents Act of 2011 S. 23: The Patent Reform Act of 2011 World Trade Organization Special 301 Submissions Russian Issues PTO Administrative Reforms DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The Leahy-Smith America Invents Act of 2011 Intellectual Property International Enforcement TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals
World Trade Organization Special 301 Submissions Russian Issues Livestock Cloning/Product Labeling Intellectual Property International Enforcement TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property Protection for Pharmaceuticals Foreign Agricultural Biotechnology Laws and Regulations Agricultural Trade Facilitation Act (Rep. Nunes Discussion Draft) Discussions with EU on Animal Cloning Korea Biotechnology Regulations China Biotechnology Regulations International Biotechnology Agreement APEC Agricultural Biotechnology Discussions Labeling of Genetically Engineered Crops U.S. Government Policy
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2011 · first_quarter · Q1
Livestock Cloning/Product Labeling World Trade Organization Special 301 Submissions Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations U.S. Position within Organization for Economic Cooperation and Development (OECD) Intellectual Property International Enforcement TransPacific Partnership Foreign Agricultural Biotechnology Laws and Regulations APEC Agricultural Biotechnology Discussions China Biotechnology Regulations Discussions with EU on Animal Cloning EU Biotechnology Bilateral Discussions European Union Low-Level Presence Policy International Biotechnology Agreement Low-Level Presence Foreign Government Policies Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization
Patent Reform S. 23: The Patent Reform Act of 2011/ H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions PTO Administrative Reforms Genetic Resource Patent Disclosure Requirement DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Amicus Matters Bayh-Dole Act/Tech Transfer Intellectual Property International Enforcement Patent Presumption of Validity Amicus Matters
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2010 · fourth_quarter · Q4
Climate Change Benefits of Biofuels and Bio-based Products Biogenic Carbon Emissions Accounting IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning U.S. Policy on International Science-Based Regulations Drug Importation S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 S.3607: Department of Homeland Security Appropriations Act for FY 2011 S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement EU Biotechnology Bilateral Discussions China Biotechnology Regulations Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2010 · third_quarter · Q3
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations Discussions with EU on Animal Cloning China Biotechnology Regulations APEC Agricultural Biotechnology Discussions Low-Level Presence Foreign Government Policies Korea Biotechnology Regulations EU Biotechnology Bilateral Discussions Turkish Biotechnology Regulations Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Drug Importation S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 S. 3607: Department of Homeland Security Appropriations Act for FY 2011 S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Export Registrations for Products with Expired Patents Alliance for Healthcare Competitiveness U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Compulsory Licensing Transpacific Partnership Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2010 · second_quarter · Q2
Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Bio-based Product Tax Credit Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman) IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 Patent Reform Cont... Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization DNA Patenting and Licensing Bayh-Dole Act/Tech Transfer Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act S.4322: Preserve Access to Affordable Generics Act PTO Administrative Reforms World Trade Organization Special 301 Submissions Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2010 · first_quarter · Q1
Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Bio-based Product Tax Credit Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman) IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Possible Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act (Discussion Draft) Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2009 · fourth_quarter · Q4
Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 S. 1733: Clean Energy Jobs and American Power Act of 2009 U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change Benefits of Biofuels and Bio-based Products Cont... Bio-based Products Tax Credit IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change/Indirect Land Use H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for 2010 H.R. 2454: American Clean Energy and Security Act of 2009 S.1733: Clean Energy Jobs and American Power Act of 2009
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Korea Living Modified Organisms Act Revisions Thailand Biotechnology Regulations Low-level Presence Foreign Government Policies U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010 S. 1213: Patient-Centered Outcomes Research Act of 2009 S.1232: Pharmaceutical Market Access Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 3590: (Senate) Patient Protection and Affordable Care Act Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning USTR, USDA & FDA Outreach to European Commission and Parliament
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2009 · third_quarter · Q3
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2009 · second_quarter · Q2
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2009 · first_quarter · Q1
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Colombia Biotechnology Bilateral Discussions Negotiations of Trans Pacific Partnership APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · second_quarter · 2A
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination Counterfeit Drugs FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 H.R. 4911 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Patient Services S. 3101: Medicare Improvements for Patients and Providers Act of 2008 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) Access to Investigation Drugs for Seriously Ill Patents The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956) Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · fourth_quarter · Q4
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2008 Clinical Trial Registry and Results Databases Drug Safety Cont... Heparin Contamination FDA Globalization Act of 2008 E-Pedigree and Anti-counterfeiting H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 S.3409: The Drug and Device Accountability Act of 2008 Funding for the Food and Drug Administration S.3289:Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 H.R. 2642: Supplemental Appropriations Act for FY 2008 H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act Stem Cell Research Medicaid Rebates Medicaid/Medicare Packages Dual Proportionality Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 Federal Trade Commission Review of Competition & IP Issues FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) S: 3230: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2642: Supplemental Appropriations Act for FY 2008 H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Outpatient Prospective Payment System S. 3101: Medicare Improvements for Patients and Providers Act of 2008 CMS ASP + 4% Proposed Regulation Medicare Reimbursement in Hospital Outpatient Setting Comparative Effectiveness Program Initiatives S. 3101 S.3408 International Market Access for U.S. Healthcare Products Alliance for Healthcare Competitiveness Funding for National Institutes of Health S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2642: Supplemental Appropriations Act for FY 2008 H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act Funding for Bioterrorism and Emergency Preparedness S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2642: Supplemental Appropriations Act for FY 2008 H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act Funding for Pandemic Influenza Preparedness S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2642: Supplemental Appropriations Act for FY 2008 H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act Drug Importation S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 S. 3181: Department of Homeland Security Appropriations Act for FY 2009 S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · third_quarter · Q3
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 S.3409: Safeguarding America's Pharmaceuticals Act of 2008 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) S: 3230: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Payment System S. 3101: Medicare Improvements for Patients and Providers Act of 2008 CMS ASP + 4% Proposed Regulation In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 S.3408 Medicare/Medicaid Packages Human Subject Protections in Clinical Trials International Market Access for U.S. Healthcare Products Alliance for Healthcare Competitiveness Funding for National Institutes of Health S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act for 2009 H.R. 7110/S.3604: Second Supplemental Appropriations Act for FY 2008 Funding for Bioterrorism and Emergency Preparedness S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act for 2009 H.R. 7110/S.3604: Second Supplemental Appropriations Act for FY 2008 Funding for Pandemic Influenza Preparedness S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act for 2009 H.R. 7110/S.3604: Second Supplemental Appropriations Act for FY 2008 Funding for the Food and Drug Administration S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 H.R. 2638: Consolidated Security, Disaster Assistance, and Continuing Appropriations Act for 2009 H.R. 7110/S.3604: Second Supplemental Appropriations Act for FY 2008 Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · second_quarter · Q2
Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Biologic Deposit Rule: 73-FR-34 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Bayh-Dole Act Evaluation Intellectual Property Enforcement Gene Patenting Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings Taiwan Biotechnology Negotiations EU Trade Negotiations Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Positions International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · first_quarter · 1A
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings French Ban on Cultivation of Biotech Seeds Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Moratorium Review of EU Labeling Regulations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Policies International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · first_quarter · 1A
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings French Ban on Cultivation of Biotech Seeds Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Moratorium Review of EU Labeling Regulations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Policies International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2008 · first_quarter · Q1
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings French Ban on Cultivation of Biotech Seeds Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Moratorium Review of EU Labeling Regulations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Policies International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2007 · year_end · YA
Small Business Innovation and Research Program (SBIR) H.R. 2720 H.R. 3567 Sarbanes-Oxley Reform Section 404 SEC and PCAOB Guidance on Auditing Standard (AS-5) FDA Waivers for Small Businesses H.R. 3580; H.R. 2900; S. 1082 FDA Regulatory Processes for First-Time Filers
Stem Cell Research Small Business Innovation and Research Program (SBIR) H.R. 2720 H.R. 3567 R&D Tax Credit (H.R. 2764) Extension Permanence Alternatives Infectious Disease Tax Credit S. 2351
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2007 · year_end · YY
Small Business Innovation and Research Program (SBIR) H.R. 2720 H.R. 3567
Sarbanes-Oxley Reform Section 404 SEC and PCAOB Guidance on Auditing Standard (AS-5)
Biobased Products Tax Credits H.R. 2419 H.R. 3586
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2007 · mid_year · MM
R&D Tax Credits H.R. 2138: Investment in America Act of 2007 Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007 FDA Appropriations Critical Path Drug Safety Human Drug Review Genetic Information Nondiscrimination S. 358 H.R. 493
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2006 · year_end · YY
Antitrust for Biodefense/Pandemic Planning and Response H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act
H.R. 4239, S. 1926: Animal Enterprise Terrorism Act
Small Business Innovative Research (SBIR) Grants H.R. 2943/S. 1263: Save America's Biotechnology Innovative Research Act Sabarnes-Oxley Reform H.R. 5405 S. 2824
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2006 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2005 · mid_year · MA
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2005 · year_end · YY
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2004 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Vice President of the U.S., White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2003 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2002 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2001 · year_end · YY
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Vice President of the U.S., White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2001 · mid_year · MM
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
BIOTECHNOLOGY INNOVATION ORGANIZATION via BIOTECHNOLOGY INNOVATION ORGANIZATION
2000 · year_end · YY
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. Trade Representative (USTR)
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning World Trade Organization Special 301 Submissions India Issues Export Registrations for Products with Expired Patents International Trade Commission Reform Rep. Devin Nunes Discussion Draft Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies EU Biotechnology Bilateral Discussions China Biotechnology Regulations European Union Low Level Presence Policy International Biotechnology Agreement Asynchrony of International Approvals Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Sanitary and Phytosanitary Issues Regulatory Transparency
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Navy, Dept of, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Biosimilars Biosimilars User Fee Act of 2012 (Discussion Draft) Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Cures Acceleration Network National Center of Advancing Translational Science (NCATS) Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Vaccine Access/Financing Adult Immunization Policies Tax for Seasonal Influenza Funding 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization Critical Path Initiative E-Pedigree and Anti-Counterfeiting Regulatory Reforms for Innovative Products Supply Chain Integrity Conflicts of Interest FDA Mission Drug Shortages Expedited Approval Pathways Access to External Experts Senate HELP Committee Discussion Draft House Energy and Commerce Committee Discussion Draft FDA Globalization Act (Discussion Draft) H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011 H.R.3214: Food and Drug Administration Mission Reform Act of 2011 H.R.4132: Faster Access to Specialized Treatments (FAST) Act H.R.3206: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 H.R.1483: Drug Safety Enhancement Act of 2011 H.R.2182: Generating Antibiotic Incentives Now Act of 2011 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Independent Payment Advisory Board H.R. 5: Protecting Access to Healthcare Act of 2011 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013 Biodefense Research, Development and Procurement S 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Part B Physician-Administered Products
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Discussions with EU on Animal Cloning APEC Agricultural Biotechnology Discussions EU Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property Protections for Pharmaceuticals
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Codex Standards Intellectual Property International Enforcement TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property for Pharmaceuticals Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement Discussions with EU on Animal Cloning China Biotechnology Regulations Low-Level Presence Foreign Government Policies European Union Low Level Presence Policy EU Biotechnology Bilateral Discussions Korea Biotechnology Regulations APEC Agricultural Biotechnology Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Potential Regulation of New Genetic Modification Technologies EU Workshop
Patent Reform H.R. 1249: The Leahy-Smith America Invents Act of 2011 S. 23: The Patent Reform Act of 2011 Implementation of H.R. 1249: The America Invents Act of 2011 IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement Intellectual Property International Enforcement TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Prescription Drug Coverage Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Vaccine Access/Financing S. 1094: Combating Autism Reauthorization Act Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Medicaid Rebates Dual Eligibles Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review Regulatory Reforms for Innovative Products Prescription Drug User Fee Act (PDUFA) Reauthorization Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 1/H.J. RES 92: Continuing Appropriations Act for FY 2011 H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Repeal Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 H.J. RES.48: Department of Defense and Further Additional Continuing Appropriations Act for FY 2011 H.R. 1/H.J. RES.92: Continuing Appropriations Act for FY 2011 Cures Acceleration Network Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Medicare Policies and Regulation
Filing targets: Agriculture, Dept of (USDA), Air Force, Dept of, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Navy, Dept of, Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Natl Security Council (NSC), Navy, Dept of, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Secretary of Defense, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act for 2011 H.R. 3082: 4th Continuing Appropriations Act for FY 2011 S. 4322: Preserve Access to Affordable Generics Act Patent Reform S. 515: The Patent Reform Act of 2009 Genetic Resource Patent Disclosure Requirement Convention on Biological Diversity DNA Patenting and Licensing Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra) Amicus Matters Possible Legislation by Rep. Wasserman Schultz Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Patent Presumption of Validity Amicus Matters
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Security Council (NSC), Navy, Dept of, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Secretary of Defense, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms Humanitarian Voucher Three Track Examination Generic Drug Patent Settlements S. 3677: Financial Services and General Government Appropriations Act of 2011 H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010 H.R. 4213: American Jobs & Closing Tax Loopholes Act Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Convention on Biological Diversity DNA Patenting and Licensing Amicus Matters Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Intellectual Property International Enforcement Compulsory Licensing
Climate Change Benefits of Biofuels and Bio-based Products Biogenic Carbon Emissions Accounting IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Alliance for Healthcare Competitiveness Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Drug Importation Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Department of Homeland Security Appropriations Act for FY 2011 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Foreign Agriculture Biotechnology Laws and Regulations Discussions with EU on Animal Cloning EU Biotechnology Bilateral Discussions Japan Biotechnology Regulations Low-Level Presence Foreign Government Policies Turkish Biotechnology Regulations Vietnam Biotechnology Regulations Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Export Registrations for Products With Expired Patents U.S. Policy on International Science-Based Regulations Intellectual Property International Enforcement Genetic Resource Patent Disclosure Requirements Convention on Biological Diversity World Intellectual Property Organization World Trade Organization Special 301 Submissions Labeling of Genetically Engineered Crops U.S. Government Policy U.S. Government Position in Codex Alimentarius Commission
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Fish & Wildlife Service (USFWS), U.S. Trade Representative (USTR), White House Office
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Discussions with EU on Animal Cloning Vietnam Biotechnology Regulations Turkish Biotechnology Regulations Low-level Presence Foreign Government Policies North America Biotechnology Initiative World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation H.R. 3590: (Senate) Patient Protection and Affordable Care Act S.1796: America's Health Future Act of 2009 H.R. 4872: Health Care and Education Reconciliation Act of 2010 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011 Department of Homeland Security Appropriations Act for FY 2011 Livestock Cloning/Product Labeling Discussion with EU on Animal Cloning Alliance for Healthcare Competitiveness Funding for International Trade Activities at the USDA (Office of the Secretary & Food Safety Inspection Service, Foreign Agricultural Service) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S.610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Gene Patenting Proposed Legislation by Rep. Wasserman Schultz Genomic Research and Accessibility Act Bayh-Dole Act/Tech Transfer HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations
Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production Livestock Cloning/Product Labeling Cont... USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product From GE Animals Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016) Efficient Review of Biotech Products U.S. Policy on Sustainable Agriculture Standard American National Standards Institute Sustainable Agriculture Standards (ANSI) International Standards Organization Standard (ISO) Funding for the USDA H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Biomass Crop Assistance Program (BCAP) BCAP Rulemaking and Environmental Impact Statement 2007 Farm Bill Implementation H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 U.S. Government Agriculture Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Agriculture Federal Research Initiative for FY 2009 Global Food Security Initiative U.S. Government Strategy for Global Food Security Codex Alimentarius Commission Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance UN Climate Change Convention US Government Position on Ag-biotech and Intellectual Property Rights
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Bayh-Dole Act/Tech Transfer Gene Patenting HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms
Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change/Indirect Land Use H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for 2010
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Tax Credit Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S.949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program Livestock Cloning/Product Labeling Cont... USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Small Business Innovation Research Program, Funding USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 USDA Foreign Agricultural Service and USTR International Coordination on Adoption of Cloning in Europe, Japan, Canada 2007 Farm Bill Implementation Discussion with EU on Animal Cloning Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Negotiations of Trans Pacific Partnership APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations Genetically Engineered (GE) Animals Coordination Between Federal Agencies USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 FDA Center for Veterinary Medicine - Regulatory Follow-up USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up NIH, Extramural Programs, Office of Laboratory Animal Welfare - rDNA Regulatory Compliance USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding USDA, Cooperative State Research Education and Extension Service, National Institute of Food and Agriculture, Small Business Innovation Research Program, Funding USDA, Foreign Agricultural Service and USTR International Coordination Upon First Approval of GE Animal Product Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016) U.S. Policy on Sustainable Agriculture Standard American National Standards Institute Sustainable Agriculture Standards (ANSI) International Standards Organization Standard (ISO) Sustainable Agriculture Research and Education (SARE) Funding for the USDA H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Biomass Crop Assistance Program (BCAP) BCAP Rulemaking and Environmental Impact Statement U.S. Government Agriculture Research Funding H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Agriculture Federal Research Initiative for FY 2009 EPA Regulations on Agriculture Biotechnology Amendments to Section 7 of the Federal Insecticide, Fungicide and Rodenticide Act Data Requirement for Pesticide Incorporated Protectants National Environmental Policy Act Implementation Global Food Security Initiative U.S. Government Strategy for Global Food Security IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization and Convention on Biological Diversity Patent Disclosure Requirements Special 301 Submissions/Meetings Bayh-Dole Act/Gene Patenting Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Incentives in Climate Change Legislation for Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 H.R. 2212/S.949: 21st Century Energy Technology Development Act Climate Change Benefits of Biofuels and Bio-based Products U.S. Government Position for U.N. Convention on Climate Change Negotiations Clean Energy Bank H.R. 2212/S. 949: 21st Century Energy Technology Development Act IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Biologic Deposit Rule: 73-FR-34 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Bayh-Dole Act Evaluation Intellectual Property Enforcement Gene Patenting Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Russia Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings Taiwan Biotechnology Negotiations EU Trade Negotiations Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Korea Trade Negotiations EU Trade Meetings World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Positions International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Intellectual Property Provisions in U.S. Trade Agreements Korean Trade Agreement
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Peru Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Paraguay Biotechnology Bilateral Discussions Transpacific Economic Partnership Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Policies Impacting Global Trade of Ag-Biotech Products Asia Pacific Economic Cooperation Forum Participation U.S. Government Positions International Market Access for U.S. Healthcare Products Alliance for Healthcare Competitiveness Intellectual Property Enforcement S.3464 Drug Importation S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 S. 3181: Department of Homeland Security Appropriations Act for FY 2009 S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009
Patent Reform H.R. 1908 S. 1145 S.3600 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Intellectual Property Enforcement S.3464
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Patent Reform H.R. 1908 S. 1145 S.3600 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Bayh-Dole Act Evaluation Intellectual Property Enforcement S.3464
Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Trade Negotiations Mexico Biotechnology Trade Negotiations Vietnam Biotechnology Negotiations France Trade Meetings Taiwan Biotechnology Negotiations EU Trade Negotiations Korea Biotechnology Trade Negotiations Canada Biotechnology Trade Negotiations Japan Biotechnology Trade Negotiations Peru Biotechnology Trade Negotiations Argentina Biotechnology Trade negotiations Adventitious Presence (Low Level Presence) U.S. Government Policy Position for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations Policies Impacting Global Trade of Ag-Biotech Products U.S. Government Positions International Market Access for U.S. Healthcare Products Alliance for Healthcare Competitiveness Drug Importation S: 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 S.3181: Department of Homeland Security Appropriations Act for FY 2009 S: 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination Counterfeit Drugs FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 H.R. 4911 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Patient Services S. 3101: Medicare Improvements for Patients and Providers Act of 2008 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) Access to Investigation Drugs for Seriously Ill Patents The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956) Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Alternative Claims Rule: 72-FR-154 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Bayh-Dole Act Evaluation International Intellectual Property Enforcement Anti-counterfeiting
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Alternative Claims Rule: 72-FR-154 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Bayh-Dole Act Evaluation International Intellectual Property Enforcement Anti-counterfeiting
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Patent Reform H.R. 1908 S. 1145 CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Alternative Claims Rule: 72-FR-154 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Bayh-Dole Act Evaluation International Intellectual Property Enforcement Anti-counterfeiting
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Animal Cloning Regulations Publication of FDA Draft Risk Assessment Study on Cloning of Livestock (H.R. 2419; H.R. 3161; H.R. 2764; S. 1859) Genetically Engineered (GE) Animals FDA and USDA Regulation of GE Animals Livestock Cloning/Product Labeling H.R. 3161 S. 1859 H.R. 2764 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855
Drug Safety H.R. 3580; H.R. 2900 S. 1082 Livestock Cloning/Product Labeling H.R. 3161 S. 1859 H.R. 2764 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 Drug Importation H.R. 3161 S. 1859 S. 1644 H.R. 2628 H.R. 2764 Animal Cloning Regulations Publication of FDA Draft Risk Assessment Study on Cloning of Livestock (H.R. 2419; H.R. 2764; H.R. 3161; S. 1859) Genetically Engineered (GE) Animals FDA and USDA Regulation of GE Animals Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence
Patent Reform H.R. 1908 S. 1145 Gene Patenting H.R. 977 ITC Exclusion Orders - Impact on Biotechnology Qualcomm Case CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Alternative Claims Rule: 72-FR-154 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Bayh-Dole Act Evaluation International Intellectual Property Enforcement Anti-counterfeiting IP Provisions in Free Trade Agreements
World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Regulations Mexico Biotech Regulations France Regulations of Plant Biotechnology Biosafety Protocol Implementation and Effect on Agricultural Biotechnology Possible U.S. Government Ratification U.S. Government Positions at Biosafety Protocol Meetings International Intellectual Property Enforcement Anti-counterfeiting ITC Exclusion Orders - Impact on Biotechnology Qualcomm Case CBD TRIPS Amendment Patent Disclosure Requirments Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Farm Subsidies in Trade H.R. 2720 Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence Restrictions on Importation of Plant Products/Lacey Act Amendments H.R. 1497 Drug Importation H.R. 3161 S. 1859 S. 1644 H.R. 2628 H.R. 2764
Medicaid Rebates H.R. 3162; H.R. 2764 S. 2499 Pharmaceutical Anti-Counterfeiting H.R. 3580; H.R. 2900 S. 1082 340B of the Public Health Service Act/Drug Prices for Covered Entitites Coverage of Different Entities S. 2499 Comparative Effectiveness Program Initiatives S. 2499 H.R. 3162; H.R. 2764; H.R. 976; H.R. 3963 Drug Importation H.R. 3161 S. 1859 S. 1644 H.R. 2628 H.R. 2764 Vaccines and Distribution/Shortage Issues H.R. 4991 S. 2456 Vaccines and Medicare Part B/Part D H.R. 4992
Biobased Products Tax Credits H.R. 2419 H.R. 3586 Biofuels Tax Credits H.R. 2776 H.R. 2419 H.R. 6 S. 2242 H.R. 5890 Biofuels Funding H.R. 3161 S. 1859 H.R. 2641 S. 1751 H.R. 2764 H.R. 2419 Biorefinery Loan Guarantees H.R. 3221 S. 1321 Renewable Fuels Standard H.R. 6 H.R. 322 S. 1321 Biorefinery Solicitation Demonstration Projects for Feedstock Culture and Collection H.R. 2419
Funding for National Institutes of Health H.R. 3043 S. 1710 H.R. 2764 Biofuels Funding H.R. 3161 S. 1859 H.R. 2641 S. 1751 H.R. 2419 H.R. 2764 Funding for Food and Drug Administration (FDA) (Critical Path Initiative; Human Drug Review) H.R. 3161 S. 1859 H.R. 2764 Funding for State Children's Health Insurance Program S. 2086; S. 1893; S. 2499 H.R. 3162; H.R. 3963; H.R. 976 Funding for the Biomedical Advanced Research & Development Authority (BARDA) H.R. 3043 S. 1710 H.R. 2764 Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764 Funding for Department of Agriculture (Biotechnology Regulatory Services) H.R. 3043 S. 1859 H.R. 2764
Animal Cloning Regulations Publication of FDA Draft Risk Assessment Study on Cloning of Livestock (H.R. 2419; H.R. 2764; H.R. 3161; S. 1859) Livestock Cloning/Product Labeling H.R. 3161 S. 1859 H.R. 2764 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 Genetically Engineered (GE) Animals FDA and USDA Regulations of GE Animals
Farm Subsidies in Trade H.R. 2720 Biobased Products Tax Credits H.R. 2419 H.R. 3586 Biofuels Tax Credit H.R. 2776 H.R. 2419 H.R. 6 S. 2242 H.R. 5890 Renewable Fuels Standard H.R. 6 H.R. 322 S. 1321 Biofuels Funding H.R. 3161 S. 1859 H.R. 2641 S. 1751 H.R. 2764 H.R. 2419 Biorefinery Solicitation Biorefinery Loan Guarantees H.R. 3221 S. 1321 Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Regulations Mexico Biotech Regulations France Regulations of Plant Biotechnology Restrictions on Importation of Plant Products/Lacey Act Amendments H.R. 2419 2007 Farm Bill (H.R. 2419) USDA Research and Regulatory Requirements for Ag-Biotech Federal Preemption Study Regarding Cloning of Livestock Study of Competitiveness of Ag-Biotech Industry Biobased Procurement -- USDA Program Demonstration Project for Feedstock Culture and Collection Biofuels Funding Importation of Plant Products Funding for Department of Agriculture (Biotechnology Regulatory Services) H.R. 3043 S. 1859 H.R. 2764 Genetically Engineered (GE) Animals FDA and USDA Regulation of GE Animals Livestock Cloning/Product Labeling H.R. 3161 S. 1859 H.R. 2764 H.R. 992 S. 414 H.R. 1396 S. 536 H.R. 4855 Animal Cloning Regulations Publication of FDA Draft Risk Assessment Study on Cloning of Livestock (H.R. 2419; H.R. 2764; H.R. 3161; S. 1859) World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings USDA Agriculture Biotechnology Regulations & Policies Release of Programmatic Environmental Impact Statement (EIS) Biotechnology Crop Stewardship Proposed Legislation Biosafety Protocol Implementation and Effect on Agricultural Biotechnology Possible U.S. Government Ratification U.S. Government Positions at Biosafety Protocol Meetings Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence EPA Regulation of Plant Agricultural Biotechnology Release of Draft Proposed Rule on Reporting Requirements for Plant Agricultural Biotechnology
Infectious Disease Tax Credit S. 2351 R&D Tax Credit (H.R. 2764) Extension Permanence Alternatives Biobased Products Tax Credits H.R. 2419 H.R. 3586 Biofuels Tax Credits H.R. 2776 H.R. 2419 H.R. 6 S. 2242 H.R. 5890 Carried Interest Tax Treatment Biotech Capital Formation Tax Incentives/Net Operating Losses H.R. 3264: American Life Sciences Competitiveness Act of 2007
Sarbanes-Oxley Reform Section 404 SEC and PCAOB Guidance on Auditing Standard (AS-5) Revenue Recognition on Collaborative Agreements SEC Guidance Carried Interest Tax Treatment Biotech Capital Formation Tax Incentives/Net Operating Losses H.R. 3264: American Life Sciences Competitiveness Act of 2007 Convertible Debt Accounting FASB Proposed Guidance
Biobased Products Tax Credits H.R. 2419 H.R. 3586 Biofuels Tax Credits H.R. 2776 H.R. 2419 H.R. 6 S. 2242 H.R. 5890 Biorefinery Loan Guarantees H.R. 3221 S. 1321 Renewable Fuels Standard H.R. 6 H.R. 322 S. 1321 Biofuels Funding H.R. 3161 S. 1859 H.R. 2641 S. 1751 H.R. 2764 H.R. 2419 Biorefinery Solicitation Demonstration Projects for Feedstock Culture and Collection H.R. 2419
Drug Safety H.R. 3580; H.R. 2900 S. 1082 Medicaid Rebates H.R. 3162 H.R. 2764 S. 2499 Comparative Effectiveness Program Initiatives H.R. 3162; H.R. 2764; H.R. 976; H.R. 3963 S. 2499 Stem Cell Research Drug Importation H.R. 3161 S. 1859 S. 1644 H.R. 2628 H.R. 2764 Funding for Food and Drug Administration (Critical Path Initiative; Human Drug Review) H.R. 3161 S. 1859 H.R. 2764 340B of the Public Health Service Act/Drug Prices for Covered Entitites Coverage of Different Entities S. 2499 FDA Regulatory Processes for First-Time Filers Food & Drug Administration Amendments Act/Food & Drug Administration Revitalization Act (H.R. 3580; H.R. 2900; S. 1082) User Fees/FDA Waivers for Small Businesses Risk Management Plans and Post-market Authorities Clinical Trial Registry and Results Databases Preemption Pharmaceutical Anti-Counterfeiting Priority Review Vouchers for Approved New Tropical Disease Therapies Civil Monetary Penalties FDA Advisory Panels/Conflict of Interest Possible Follow-on Biologics Amendments Follow-on Biologics H.R. 1038 H.R. 1956 S. 1695 S. 623 Presciption Drug User Fees H.R. 3580; H.R. 2900 S. 1082 Vaccines for Children Program H.R. 4990 Vaccines for Uninsured Adults H.R. 4993 National Vaccine Immunization Rates National Vaccine Program Office Working Paper on Adolescent Immunization Influenza Immunization Physician Quality Reporting Inititiative Vaccine Financing National Vaccine Program Office Draft White Paper on Vaccine Financing Vaccines and Medicare Part B/Part D H.R. 4992 Vaccines and Distribution/Shortage Issues H.R. 4991 S. 2456 Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764 BARDA and Project BioShield HHS Implementation Plans Funding (H.R. 3043; S. 1710; H.R. 2764) Emerging Diseases Regulatory Processes Emergency Use Authorization Genetic Testing Regulatory Oversight Infectious Disease Research Tax Credit S. 2351 Funding for State Children's Health Insurance Program S. 2086; S. 1893; S. 2499 H.R. 3162; H.R. 3963; H.R. 976 Pharmaceutical Anti-Counterfeiting H.R. 3580; H.R. 2900 S. 1082 Erythropiesis Stimulating Agents CMS National Coverage Decision
Vaccines and Distribution/Shortage Issues H.R. 4991 S. 2456 BARDA and Project BioShield HHS Implementation Plans Funding (H.R. 3043; S.1710; H.R. 2764) Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764
Funding for National Institutes of Health H.R. 3043 S. 1710 H.R. 2764 BARDA and Project BioShield HHS Implementation Plans Funding (H.R. 3043; S.1710; H.R. 2764) Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764 Critical Path Inititive H.R. 3161 S. 1859 Stem Cell Research Genetic Testing Regulatory Oversight Infectious Disease Reserach Tax Credit S. 2351 Comparative Effectiveness Program Initiatives S. 2499 H.R. 3162; H.R. 2764; H.R. 976; H.R. 3963
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Patent Reform H.R. 1908 S. 1145
Biobased Products Tax Credits H.R. 2419 H.R. 3586
Infectious Disease Tax Credit S. 2351
World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings
Stem Cell Research
Farm Subsidies in Trade H.R. 2720
Drug Safety H.R. 3580; H.R. 2900 S. 1082
Medicaid Rebates H.R. 3162; H.R. 2764 S. 2499
Funding for National Institutes of Health H.R. 3043 S. 1710 H.R. 2764
Animal Cloning Regulations Publication of FDA Draft Risk Assessment Study on Cloning of Livestock (H.R. 2419; H.R. 2764; H.R. 3161; S. 1859)
Drug Safety H.R. 3580; H.R. 2900 S. 1082
Vaccines and Distribution/Shortage Issues H.R. 4991 S. 2456
Funding for National Institutes of Health H.R. 3043 S. 1710 H.R. 2764
Adventitious Presence U.S. Government Policy Position for Codex Guidelines on Adventitious Presence
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
340B of the Public Health Service Act/Drug Prices for Covered Entities Administrative Interpretations of Pricing Calculations Guidance on Calculation of 340B Ceiling Price Medicaid Expansion/Rebates H.R. 3162: The Children's Health and Medicare Protection Act of 2007 S.1893: The Children's Health Insurance Program Reauthorization Act of 2007 Medicare Part D "Non-Interference" Proposals S.250 and H.R. 4: Medicare Prescription Drug Price Negotiation Act
Codex Biotechnology Agenda U.S. Government Food Standards Negotiations Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations India Agricultural Biotechnology Regulations China Biotechnology Regulations Mexico Biotech Regulations International Policy Regarding Agricultural Biotechnology U.S. Government Negotiation Positions World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings USDA Agriculture Biotechnology Regulations USDA Biotechnology Policies Federal Preemption Oversight of Industry Exports of Agricultural Biotechnology Products Agricultural Biotechnology Stewardship Cartagena Biosafety Protocol Implementation and Effect on Agricultural Biotechnology CBD TRIPS Amendment Genetic Origin Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Intellectual Property Protections as Part of Panama and Peru Free Trade Agreements International Intellectual Property Enforcement Bill ITC Exclusion Orders - Impact on Biotechnology ITC Remedy Qualcomm Case
Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation
Sarbanes-Oxley Section 404 Reform Small Business Innovation Research (SBIR) Funding
Sarbanes-Oxley Section 404 Reform
Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008 S. 1751: Energy and Water Development Appropriations Act, FY 2008 H.J.Res 20: Revised Continuing Appropriations Resolution, 2007 Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations India Agricultural Biotechnology Regulations China Biotechnology Regulations Mexico Biotech Regulations International Policy Regarding Agricultural Biotechnology U.S. Government Negotiation Position World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings Codex Biotechnology Agenda U.S. Government Food Standards Negotiations USDA Agriculture Biotechnology Regulations USDA Biotechnology Policies Federal Preemption Oversight of Industry Exports of Agricultural Biotechnology Products Agricultural Biotechnology Stewardship 2007 Farm Bill Animal Welfare Biofuels/Energy Research Preemption Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants Funding for Biotechnology Regulatory Services/USDA FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act Cartagena Biosafety Protocol Implementation and Effect on Agricultural Biotechnology Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Energy Conservation Tax Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007
Drug Safety H.R. 2900: FDA Administration Amendments Act of 2007 (FDAAA) S.1082: FDA Revitalization Act (FDARA) Follow-on Biologics H.R. 1956: Patient Protection and Innovative Biologic Medicines Act S. 6237: Access to Life-Saving Medicines Act H.R. 1038: Access to Lifesaving Medicines Act S.1695: Biologics Price Competition and Innovation Act of 2007 Medicaid Expansion/Rebates H.R. 3162: The Children's Health and Medicare Protection Act of 2007 S.1893: The Children's Health Insurance Program Reauthorization Act of 2007 Medicare Clinical Trial Coverage Policy Implementation of Medicare Clinical Research Policy National Coverage Decision Comparative Effectiveness Research Initiatives S.3: Medicare Prescription Drug Price Negotiation Act of 2007 Medicare Part D "Non-Interference" Proposals S.250 and H.R. 4: Medicare Prescription Drug Price Negotiation Act FDA Appropriations Critical Path; Drug Safety; Human Drug Review Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043:Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Approp. Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 340B of the Public Health Service Act/Drug Prices for Covered Entities Administrative Interpretations of Pricing Calculations Guidance on Calculation of 340B Ceiling Price Genetic Information Nondiscrimination S. 358 H.R. 493 Drug Importation S.1082: FDA Revitalization Act (FDARA) Biodefense Implementation Plan and Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Vaccines for Children Contract Data Availability Request
Biotech Tax Package H.R. 3264: American Life Sciences Competitiveness Act of 2007 Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 R&D Tax Credit H.R. 2138: Investment in America Act of 2007 Cross Licensing Agreement Taxation Treasury Department Proposal
Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 R&D Tax Credit H.R. 2138: Investment in America Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Engery and Water Development and Related Agencies Appropriations Act, FY 2008 S. 1751: Energy and Water Development Appropriations Act, FY 2008 H.J. Res 20: Revised Continuing Appropriations Resolution, 2007 Small Business Innovation Research (SBIR) Funding Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007
FDA Appropriations Critical Path Drug Safety Human Drug Review Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biotechnology Regulatory Services/USDA FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008 S.1751: Energy and Water Development Appropriations Act, FY 2008 H.J.Res 20: Revised Continuing Appropriations Resolution, 2007 Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007
Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants Drug Importation S.1082: FDA Revitalization Act (FDARA) Drug Safety H.R. 2900: FDA Administration Amendments Act of 2007 (FDAAA) S.1082: FDA Revitalization Act (FDARA)
Genetic Information Nondiscrimination S. 358 H.R. 493
Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008; S. 1751: Energy and Water Development Appropriations Act, FY 2008; H.J. Res 20: Revised Continuing Appropriations Resolution, 2007 Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007
Biodefense Implementation Plan and Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008
Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Engery and Water Development and Related Agencies Appropriations Act, FY 2008; S. 1751: Energy and Water Development Appropriations Act, FY 2008; H.J.Res 20: Revised Continuing Appropriations Resolution, 2007
Patent Reform H.R. 1908: Patent Reform Act of 2007 S. 1145: Patent Reform Act of 2007 Bayh-Dole Act PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71 FR 38808 CBD TRIPS Amendment Genetic Origin Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Intellectual Property Protections as Part of Panama and Peru Free Trade Agreements International Intellectual Property Enforcement Bill ITC Exclusion Orders - Impact on Biotechnology ITC Remedy Qualcomm Case Substantive Patent Law Harmonization U.S. Government Negotiation Positions Gene Patenting H.R. 977: A bill to prohibit gene patents
Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Adventitious Presence FDA's Adventitious Presence Policy Release of USDA's Precursor to APHIS 340 Regs Change; USDA CFR 7 Part 340 Animal Transgenics and Cloning FDA Draft Risk Assessment on Animal Cloning
World Health Organization Access to Medicines CBD TRIPS Amendment Genetic Origin Disclosure Requirements Patent Courts H.R. 5418 PTO Proposed Regulations Continuation Applications: 37 CFR Part 1 Information Disclosures Rules : 71 FR 38808 Claims Rules Intellectual Property Aspects of US Malaysia Free Trade Agreement Genetic Origin Disclosure Requirements Patenting of Plants and Animals Intellectual Property Aspects of US Korea Free Trade Agreement Data Exclusivity Patent Linkage Patent Reform S. 3818: Patent Reform Act of 2006
Sarbanes-Oxley Reform H.R. 5405 S.2824
Cellulosic Ethanol Funding H.R. 5427: Energy and Water Appropriations Act, 2007 Cellulose Ethanol Tax Credit H.R. 5890: American Made Energy Freedom Act
Cellulosic Ethanol Funding H.R. 5427: Energy and Water Appropriations Act, 2007 Adventitious Presence FDA's Adventitious Presence Policy EPA's Adventitious Policy Release of USDA's Precursor to APHIS 340 Regs Change USDA CFR 7 Part 340 Revision of Regulations for Agricultural Biotechnology 7 CFR Part 340 (Draft EIS and Changes to Part 340) Establishment of Reporting Requirements for Agricultural Biotechnology Revision of Regulations in Section 7 FIFRA (Federal Insecticide Fungicide and Rodenticide Act) Cellulose Biomass Ethanol Tax Credit H.R. 5890: American Made Energy Freedom Act Funding for Biotechnology Regulatory Services/USDA H.R. 5384 Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations Indian Agricultural Biotechnology Regulations Sri Lanka Biotechnology Regulations EU Biotechnology Regulations China Biotechnology Regulations Mexico Biotechnology Regulations Codex Biotechnology Agenda U.S. Government Food Standards Negotiations Cartagena Biosafety Protocol Implementation of the Biosafety Protocol and Effect on Agricultural Biotechnology World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings
Tricare Retail Pharmacy H.R. 5122, S. 2767: Department of Defense Authorization
H.R. 1227, S. 306: Genetic Information Nondiscrimination Act
Drug Importation H.R. 5441: FY2007 Homeland Security Appropriations Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations Indian Agricultural Biotechnology Regulations Sri Lanka Biotechnology Regulations EU Biotechnology Regulations China Biotechnology Regulations Mexico Biotechnology Regulations Cartagena Biosafety Protocol Implementation of the Biosafety Protocol and Effect on Agricultural Biotechnology World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings Pharmaceutical Coverage and Pricing U.S. Korea Free Trade Agreement Intellectual Property Aspects of US Korea Free Trade Agreement Data Exclusivity Patent Linkage Intellectual Property Aspects of US Malaysia Free Trade Agreement Genetic Origin Disclosure Requirements Patenting of Plants and Animals
Orphan Drug Research H.R. 5080: Orphan Drug Tax Credit Funding for Pandemic Preparedness H.R. 5647: Labor/HHS/Education Appropriations H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act Funding for Critical Path at FDA H.R. 5384: Agriculture and Related Agencies Appropriations Stem Cell Research H.R. 810: Stem Cell Research S. 2504: Fetus Farming Prohibition Act R&D Tax Credits H.R. 5115: U.S. Healthcare Technologies Competitiveness Act of 2006 H.R. 4082/S. 189: Biotechnology Future Investment Act of 2005 FDA Funding H.R. 5384 2008 Budget
Stem Cell Research H.R. 810: Stem Cell Research S. 2504: Fetus Farming Prohibition Act R&D Tax Credit H.R. 5115: U.S. Healthcare Technologies Competitiveness Act of 2006 Small Business Innovation Research (SBIR) Grants H.R. 2943/S 1263: Save Biotechnology Innovative Research Act of 2005 Cellulosic Ethanol Research Funding H.R. 5427: Energy and Water Appropriations Orphan Drug Research H.R. 5080: Orphan Drug Tax Credit Cellulosic Ethanol Tax Credit H.R. 5890: American Made Energy Freedom Act
H.R. 5384: Agriculture and Related Agencies Appropriation Funding for Critical Path at FDA Funding for Biotechnology Regulatory Services/USDA H.R. 5647: Labor/HHS/Education Appropriations Funding for Pandemic Preparedness H.R. 5427: Energy and Water Appropriations Funding for Cellulose Ethanol Funding H.R. 5441: FY 2007 Homeland Security Appropriations Drug Importation
Medicaid Program Rebates S.1932: Deficit Reduction Act Drug Importation H.R. 5441: FY2007 Homeland Security Appropriations Ryan White Care Act Reauthorization Covered Drugs List/ADAPs Tricare Retail Pharmacy H.R. 5122, S. 2767: Department of Defense Authorization Biodefense and Pandemic Vaccine Tracking S.3678: Pandemic & All-Hazards Preparedness Act Implementation of Deficit Reduction Act 340B Pricing S. 1932: Deficit Reduction Act
Funding for Pandemic Preparedness H.R. 5647: Labor/HHS/Education Appropriation H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense & Pandemic Biodefense Advanced R&D and Procurement Reform H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Biodefense and Pandemic Regulatory Guidance Vaccine Tracking Information Disclosure S. 3678: Pandemic and All-Hazards Preparedness Act Antitrust Exemptions H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense Information Technology to Improve Situational Awareness S.3678: Pandemic & All-Hazards Preparedness Act
Cellulosic Ethanol Funding H.R. 5427: Energy and Water Appropriations Act, 2007 Cellulose Biomass Ethanol Tax Credit H.R. 5890: American Made Energy Freedom Act
Drug Safety S:3807: Enhancing Drug Safety and Innovation Act of 2006 Drug Importation H.R. 5441: FY2007 Homeland Security Appropriations Adventitious Presence FDA's Adventitious Presence Policy EPA's Adventitious Policy Release of USDA's Precursor to APHIS 340 Regs Change USDA CFR 7 Part 340 Animal Transgenics and Cloning FDA Draft Risk Assessment on Animal Cloning
FDA's Critical Path Initiative Funding Specific Projects Follow-on Biologics H.R. 6237: Access to Lifesaving Medicines Act FDA Funding H.R. 5384 2008 Budget Drug Safety S:3807: Enhancing Drug Safety and Innovation Act of 2006 Drug Importation H.R. 5441: FY2007 Homeland Security Appropriations Prescription Drug User Fee Act Reauthorization Critical Path Drug Safety Drug Reviews Biodefense & Pandemic Biodefense Advanced R&D and Procurement Reform H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Biodefense Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Biodefense and Pandemic Regulatory Guidance Vaccine Tracking Information Disclosure S. 3678: Pandemic and All-Hazards Preparedness Act Funding H.R. 5647: Labor/HHS/Education Appropriations H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: Pandemic and All-Hazards Preparedness Act Antitrust Exemptions H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S. 3678: "Pandemic and All-Hazards Preparedness Act Biodefense Information Technology to Improve Situational Awareness S.3678: Pandemic & All-Hazards Preparedness Act Genetic Information Nondiscrimination H.R. 1227, S. 306 Ryan White Cases Act Reauthorization Covered Drugs List/ADAP Medicaid Program Rebates S. 1932: Deficit Reduction Act Implementation of Deficit Reduction Act 340B Pricing S. 1932: Deficit Reduction Act Tricare Retail Pharmacy H.R. 5122, S. 2767: Department of Defense Authorization
Animal Transgenics and Cloning FDA Draft Risk Assessment on Animal Cloning
Implementation of Deficit Reduction Act 340B Pricing S. 1932: Deficit Reduction Act Coding for Physician-Administered Biologics Ryan White Care Act Reauthorization Covered Drugs List/ADAP Medicaid Program Rebates S.1932: Deficit Reduction Act
R&D Tax Credits H.R. 5115: U.S. Healthcare Technologies Competitiveness Act of 2006 Orphan Drug Research Tax Credit H.R. 5080 Cellulose Ethanol Tax Credit H.R. 5890: American Made Energy Freedom Act Net Operating Losses H.R. 4082/S 1893: Biotechnology Future Investment Act of 2005 Biotechnology Investment Incentives H.R. 5115: US Healthcare Technologies Competitiveness Act of 2006
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)